Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease
NCT02111122
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Sleep-wake Disturbances in Motor-phase Parkinson's Disease
Interventions
DRUG:
Sodium Oxybate
DRUG:
Placebo
Sponsor
Christian Baumann